These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9311723)

  • 1. Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses.
    Geissler EK; Korzun WJ; Graeb C
    Transplantation; 1997 Sep; 64(5):782-6. PubMed ID: 9311723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivo.
    Geissler EK; Scherer MN; Graeb C
    Transpl Int; 1998; 11 Suppl 1():S357-60. PubMed ID: 9665015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation].
    Geissler EK; Scherer MN; Jauch KW; Graeb C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):641-4. PubMed ID: 14518333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
    Graeb C; Scherer MN; Knechtle SJ; Geissler EK
    Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.
    Graeb C; Scherer MN; Kroemer A; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):948-54. PubMed ID: 12368047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model.
    Behrens D; Lange K; Fried A; Yoo-Ott KA; Richter K; Fändrich F; Krönke M; Zavazava N
    Transplantation; 2001 Dec; 72(12):1974-82. PubMed ID: 11773898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model.
    Geissler EK; Scherer MN; Graeb C
    Transpl Int; 2000; 13 Suppl 1():S452-5. PubMed ID: 11112052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.
    Geissler EK; Graeb C; Tange S; Guba M; Jauch KW; Scherer MN
    Hum Gene Ther; 2000 Feb; 11(3):459-69. PubMed ID: 10697120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system.
    Wang M; Stepkowski SM; Wang ME; Tian L; Qu X; Tu Y; He G; Kahan BD
    Transplantation; 1996 Feb; 61(3):448-57. PubMed ID: 8610360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex.
    Knechtle SJ; Wang J; Jiao S; Geissler EK; Sumimoto R; Wolff J
    Transplantation; 1994 Apr; 57(7):990-6. PubMed ID: 8165719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.
    Geissler EK; Wang J; Fechner JH; Burlingham WJ; Knechtle SJ
    J Immunol; 1994 Jan; 152(2):413-21. PubMed ID: 8283029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
    Garrovillo M; Ali A; Oluwole SF
    Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses.
    Priestley CA; Dalchau R; Sawyer GJ; Fabre JW
    Transplantation; 1989 Dec; 48(6):1031-8. PubMed ID: 2595764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.